
Emily Fisher is a passionate entrepreneur and healthcare advocate dedicated to helping others by unlocking the incredible potential of cannabis as medicine. As a breast cancer survivor and medical cannabis patient herself, Emily understands the life-changing benefits of cannabis and the challenges many patients face in accessing this important medicine. With this firsthand experience, she founded Leafwell to provide patients with greater access to medical cannabis and education and research about its therapeutic value.
Under Emily’s leadership, Leafwell has grown into an industry-leading technology and data company that has successfully served over 300,000 patients across 35 states in the United States. Each month, the company’s website receives more than 750,000 visitors eager to learn more about the benefits of medical cannabis and how it can help them with various health conditions.
Driven by her personal mission, Emily has focused on building a compassionate and knowledgeable team at Leafwell committed to understanding cannabis as medicine and sharing this critical information with the world. In doing so, she hopes that millions more people will find the relief they need and deservedly improve their quality of life.
Emily’s unwavering belief in the power of cannabis has led her to become an influential voice in the industry. Through Leafwell, she advocates for increased access, education, and research into cannabis so that it can be recognized and utilized as a legitimate and effective form of medicine for countless patients worldwide.
Attend Cannabis Europa London 2026
26–27 May 2026 · The Barbican, London · Europe's leading cannabis industry conference
General Release
VIP Experience
BoC Awards
Working with Prohibition Partners for Cannabis Europa has been an absolute pleasure. Their dedication, exceptional professionalism, and collaborative spirit have made a meaningful difference, and we sincerely value their support.

We were truly honoured to sponsor the VIP Lounge and be part of an event that continues to set the standard for meaningful dialogue and progress in the medical cannabis industry. We left feeling excited and optimistic about the future.
